Living you are putting the wrong financial slant on your overall outlook concerning DR-70/Onko-Sure.
"DR-70 can detect 19 different types of cancer, that is the benefit of DR-70..Combined with Provista's IP it is a better test in all 19...Now Provista can get the New Generation test FDA approved more quickly...We are sitting on a "Diamond In The Rough" You understand....Wolf"
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.